Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial
Open Access
- 27 January 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 24
- https://doi.org/10.1186/1745-6215-12-24
Abstract
By tradition colloid solutions have been used to obtain fast circulatory stabilisation in shock, but high molecular weight hydroxyethyl starch (HES) may cause acute kidney failure in patients with severe sepsis. Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units (ICUs) and 1st choice fluid for patients with severe sepsis. However, HES 130/0.4 is largely unstudied in patients with severe sepsis.Keywords
This publication has 32 references indexed in Scilit:
- The Effects of Hydroxyethyl Starch 130/0.4 (6%) on Blood Loss and Use of Blood Products in Major Surgery: A Pooled Analysis of Randomized Clinical TrialsAnesthesia & Analgesia, 2008
- Preferences for colloid use in Scandinavian intensive care unitsActa Anaesthesiologica Scandinavica, 2008
- Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsisBMC Emergency Medicine, 2008
- Colloid solutions for fluid resuscitationPublished by Wiley ,2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Colloids versus crystalloids for fluid resuscitation in critically ill patientsPublished by Wiley ,2007
- Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised studyThe Lancet, 2001
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992